13.05.2015
- Former US-based generics producer Perrigo, now headquartered in Ireland, has acquired the Mexican operations of contract drug development and manufacturing services provider...
30.04.2015
- Still being pursued by Israeli generics giant Teva, Netherlands-based drugmaker Mylan has increased its offer to acquire the issued and to-be-issued shares of smaller generics...
28.04.2015
- In its first reaction to the hostile takeover bid by Israeli generics giant Teva, the board of Dutch-based drugmaker Mylan has unanimously rejected the more than $40 billion offer...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
22.04.2015
- In what is shaping up to be the global pharmaceutical industry's latest hostile takeover struggle, the world's largest generic drugmaker, Israel-based Teva, has made a bid for...
12.04.2015
- Generic drugmaker Mylan has made an offer of $ $28.86 billion in stock and cash to acquire rival Perrigo. A merger of the two major players would create a leader in specialty drugs...
12.08.2014
- US generic drugmaker Mylan has shaved the top end of its full-year revenue and earnings forecasts slightly, citing delays in approval from the US Food and Drug Administration for...
15.07.2014
- Generic drugmaker Mylan said it plans to acquire Abbott Laboratories' branded specialty and generics business in developed markets outside the US for $5.3 billion. Both companies...
